Compare AMC ENTERTAINMENT HOLDINGS, INC. (AMC) vs Gilead Sciences, Inc. (GILD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AMC ENTERTAINMENT HOLDINGS, INC. vs Gilead Sciences, Inc. — how do they compare? AMC ENTERTAINMENT HOLDINGS, INC. trades at $2.4 (market cap $2.14B), while Gilead Sciences, Inc. trades at $135.47 (market cap $168.35B). The key difference: Gilead Sciences, Inc. is far larger — about 78.7× AMC ENTERTAINMENT HOLDINGS, INC.'s market cap, and Gilead Sciences, Inc. pays the higher dividend (2.42%). Which is the better fit depends on your goals.
| AMC | GILD | |
|---|---|---|
Market Cap | $2.14B | $168.35B |
Sector | Media | Health |
52-Week High | $3.15 | $155.80 |
52-Week Low | $0.95 | $110.56 |
Enterprise Value | $9.08B | $191.42B |
Dividend Yield | 0.11% | 2.42% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AMC ENTERTAINMENT HOLDINGS, INC.
AMC Entertainment Holdings, Inc. operates as a holding company. The Company, through its subsidiaries, provides theatrical exhibition, movie screening, food distribution, online ticket booking, and other related services. AMC Entertainment offers movie theaters worldwide.
Read more on AMC →About Gilead Sciences, Inc.
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.
Read more on GILD →
